ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

0ABW Egetis Therapeutics Ab (publ)

0.00
0.00 (0.00%)
Last Updated: -
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End 31 December 2023 20162017201820192020202120222023
SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)
Total Assets 396.44M315.37M242.04M270.07M893.97M569.3M561.1M760.2M
Total Current Assets 396.44M315.37M242.04M269.95M299.87M152.9M147.3M345.9M
Cash and Equivalents 394M309.53M229.88M255.1M287.85M144M127.7M303.3M
Total Non-Current Assets 389.56M303.71M219.36M244.88M629.63M527M506.2M545.6M
Total Liabilities 6.87M11.66M22.68M25.2M264.34M42.3M54.9M214.6M
Total Current Liabilities 6.87M11.66M22.68M25.08M70.14M39.2M49.4M103.9M
Total Non-Current Liabilities 000232k197.73M5.8M6.6M214.1M
Total Equity 389.56M303.71M219.36M244.88M629.63M527M506.2M545.6M
Common Equity 2.56M2.56M2.56M2.82M8.69M8.7M11.3M15.4M
Retained Earnings -38.22M-316.79M-401.8M-463.22M-642.35M-745.8M-939.6M-1.27B